loader image
By Joan van Wyngaard, The Ingredients Doctor™  | B.Pharm, M.Sc (Pharmacology), MBA, PhD

The Multi-Billion Rand Market, the Science It Doesn’t Want You to Read, and the Three Forms That Actually Work

The global collagen supplement market is now valued in the tens of billions of dollars. Walk into any pharmacy and you will find collagen coffees, gummies, sachets, shots, and drinks, all promising to reverse ageing and rebuild what time has taken away. As a PhD pharmacist who has spent her career evaluating ingredient data, I have a professional obligation to tell you what the science actually says — and what it doesn’t.

This is not a post against collagen. This is a post for precision. Not all collagen is equal. Not all delivery mechanisms are equivalent. And the form that receives the most marketing spend is, ironically, the one with the weakest independent evidence. Let us start at the biology.

What Happens When You Swallow Collagen

 Collagen is the most abundant structural protein in the human body. It forms the scaffolding of skin, tendons, ligaments, cartilage, bone, blood vessel walls, and fascia. The collagen in your skin is a precisely organised triple helix of three polypeptide chains, cross-linked and maintained by the activity of dermal fibroblast cells. It does not simply sit there — it is a dynamic structure, continuously degraded by matrix metalloproteinases (MMPs) and synthesised anew by fibroblasts in a cycle that slows dramatically with age.

When you swallow collagen, your digestive system treats it the same way it treats any protein you consume. Stomach acid begins denaturation. Proteolytic enzymes — pepsin in the stomach, trypsin and chymotrypsin in the small intestine — cleave the polypeptide chains into peptides and ultimately amino acids. What is absorbed into the bloodstream is primarily a pool of amino acids: glycine, proline, hydroxyproline, alanine, and others.

Here is the critical point that most collagen marketing omits: once those amino acids enter the bloodstream, your body distributes them according to its own metabolic priorities. There is no GPS system that says ‘send this glycine specifically to the face’. Amino acids are generic building blocks. Whether they came from a R299 collagen powder or a piece of grilled chicken or a bowl of legumes is, from the body’s perspective, irrelevant.

The triple helix structure that defines collagen — the structural element that gives it its mechanical properties — is destroyed long before the amino acids reach your bloodstream. You are not supplementing collagen. You are supplementing its amino acid components.

The Evidence Problem

The clinical literature on hydrolysed collagen supplementation is technically substantial. There are many published studies. The issue is not the volume of research but its quality and independence.

When you apply the standards used in pharmaceutical regulatory review to this literature, several patterns emerge consistently:

  • The majority of positive trials are industry-funded. The relationship between funding source and outcome direction in nutrition supplement research is well documented in the broader scientific literature.
  • Sample sizes are frequently small (30–60 volunteers) and study durations short (4–12 weeks). Statistical significance in small short-duration studies is more easily achieved and less reliably predictive of real-world outcomes.
  • Outcome measures are often self-reported: ‘skin feels smoother’, ‘I notice less dryness’. These are not the same as Cutometer® elasticity measurements, 3D profilometry of wrinkle depth, or transepidermal water loss (TEWL) assessment by a calibrated probe.
  • Where objective measurements are used, the results are typically modest and variable across independent studies.

Independent systematic reviews — those without commercial sponsorship — consistently characterise the evidence for hydrolysed collagen improving skin appearance as preliminary and inconsistent. Effect sizes, where real, are modest. Confidence intervals are wide. Replication across independent research groups is limited.

This does not mean hydrolysed collagen has no effect whatsoever. The amino acid precursor argument is biologically plausible: fibroblasts do respond to increased availability of glycine and hydroxyproline by upregulating synthesis. But this is a general nutritional effect, not a unique mechanism. And it can be replicated through adequate dietary protein intake without any supplement at all.

The question — the one the marketing never invites you to ask — is whether the specific collagen in the specific product delivers a clinically meaningful, measurable difference compared to a matched placebo, in a well-designed, independently funded trial, using objective endpoints. For most hydrolysed collagen drinks on the market: the answer is not clearly yes.

What Actually Works: Three Forms with Real Biological Rationale

Not all collagen is the same. The category distinction matters enormously, and once you understand the mechanism behind each form, the difference in evidence quality makes complete sense.

1. Eggshell Membrane (INNAĪN® ESM®) — Native, Multi-Type, Structurally Intact

Eggshell membrane is the thin inner membrane of the chicken egg (Gallus gallus) that lines the inside of the shell. From a biochemical standpoint, it is one of the most compositionally interesting sources of connective tissue matrix in nature — and it has not been hydrolysed.

ESM® composition per INNAĪN® specification: •  Native Collagen Types I, V, and X (minimum 25%) •  Elastin (minimum 25%) • Hyaluronic Acid, Chondroitin Sulphate, Glucosamine Sulphate (each up to 2%)  This is the complete connective tissue matrix in a single ingredient.

The key distinction from hydrolysed collagen is structural. ESM® provides native, undenatured collagen — the intact triple helix and associated structural proteins preserved as they exist in biological tissue. This matters for two reasons. First, native collagen fibrils interact with cell surface receptors differently from free peptides or amino acids, potentially triggering more specific biological responses. Second, for cartilage-specific applications, the structural integrity of the collagen molecule is required for the oral tolerance mechanism described below.

The eggshell membrane also provides elastin — the protein responsible for skin and tissue elasticity and recoil — alongside all three glycosaminoglycans (hyaluronic acid, chondroitin sulphate, and glucosamine sulphate) in a single source. This comprehensive connective tissue matrix is why the joint and tissue recovery data on ESM® is as robust as it is.

The ESM® Clinical Evidence

INNAĪN® ESM® has been investigated in multiple randomised controlled trials using validated, objective clinical endpoints — specifically the VAS (Visual Analogue Scale for pain) and the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index, a validated questionnaire measuring pain, stiffness, and functional capacity). These are the same tools used in pharmaceutical clinical trials for joint health.

Study Design

Duration

Endpoints Used

Key Finding

RCT — joint pain (osteoarthritis)

7 days

VAS pain score

Significant improvement vs placebo within first week

RCT — osteoarthritis management

8 weeks

VAS + WOMAC (pain, stiffness, function)

Safe and effective for chronic management; reduced pain, improved functionality and stiffness vs placebo

RCT — 300mg preventive dose

Variable

VAS + functional measures

Favourable results on pain reduction and functional improvement at preventive dose

In vitro study — collagen synthesis

Cell model

COL3A1 gene expression, decorin, MMP-2

Stimulated Type III collagen gene expression; increased decorin + MMP-2 expression

An independent comparative analysis of clinical trials published in PubMed concluded that the INNAĪN® ESM® study design — with rigorous controlled design, objective functional endpoints, and standardised product — represents the most robust reference currently available for therapeutic use of eggshell membrane in osteoarthritis treatment.

ESM® is also effective in sport recovery contexts: its proven anti-inflammatory properties alongside the regenerative capacity of its components support reduction of post-exercise pain, reduction of stiffness, increase of functional capacity, and acceleration of recovery — confirmed in both cell models and human clinical trials.

ESM® is the primary collagen active in Vitadurance Joint Active — at 500mg per capsule, the therapeutically studied dose.

2. Native Undenatured Type II Collagen — The Cartilage Mechanism

Type II collagen is the dominant structural collagen of articular cartilage — the smooth tissue lining joint surfaces. Native (undenatured) means the triple helix structure is intact, and specifically that the immunological epitopes on the collagen molecule are preserved.

The mechanism here is oral tolerance. When native Type II collagen is consumed in small, intact doses, the gut-associated lymphoid tissue (GALT) — specifically the Peyer’s patches of the small intestine — recognises the collagen epitopes and generates regulatory T-cells that specifically suppress immune-mediated attack on cartilage collagen. In osteoarthritis and rheumatoid arthritis contexts, this dampens the inflammatory destruction of the joint surface.

This mechanism is documented specifically for native, undenatured Type II collagen. Hydrolysed Type II collagen loses the structural epitopes required to trigger the oral tolerance response. The hydrolysis process destroys them. This is why ‘collagen Type II’ in a hydrolysed drink and native undenatured Type II collagen in a capsule are not interchangeable from a mechanistic standpoint, even if the marketing language treats them as equivalent.

Vitadurance Joint Active contains 40mg native undenatured Type II collagen per capsule, alongside the ESM® complex, creating dual-axis collagen support: ESM® for the full connective tissue matrix including tendons, ligaments, and fascia, and native Type II for cartilage-specific immune tolerance.

 

3. Collage™ Topically — Delivering Where It Needs to Go

The topical route to collagen support represents a fundamentally different approach — and in many ways, a more direct one. Instead of ingesting collagen and relying on systemic distribution to the dermis, topical application can deliver active compounds directly to the tissue layer where fibroblasts live and collagen is synthesised.

Collage™ is an ALGAKTIV® marine biotech active sourced from Haematococcus pluvialis microalgae, produced under a sustainable upcycling model. It is a 2-in-1 complex combining two distinct mechanisms:

  • Component 1 — Vegan collagen amino acids — the exact structural trio that forms the majority of native collagen fibres: glycine, proline, and hydroxyproline. Delivered directly to the dermal layer, these provide the building block substrates that fibroblasts use to synthesise new collagen, without the digestive dilution of the oral route.
  • Component 2 — Spermidine — a growth factor-like polyamine that upregulates COL1A1 and COL3A1 gene expression (stimulating Type I and III collagen production), induces autophagy (cellular self-renewal), boosts cellular energy, and enhances fibroblast proliferation. Spermidine is gaining significant attention in the longevity and cellular ageing science literature for its role in promoting cellular renewal via the autophagy pathway.

The evidence behind Collage™ is presented with full transparency about study concentrations — because the formulator owes you that precision.

Study

Concentration

Timepoint

Outcome

Study Type

Collagen I increase

3%

24 hours

+40.37%

IN VITRO

Barrier integrity

3%

24 hours

+34.3%

IN VITRO

Aquaporin 5 (moisture channel)

3%

24 hours

+25.9%

IN VITRO

Aquaporin 3 (moisture channel)

3%

24 hours

+25.6%

IN VITRO

Wrinkle reduction (instant)

3%, single application

10 minutes

-13.7%

IN VIVO

Hydration (instant)

3%, single application

10 minutes

+24.9%

IN VIVO

Moisturising

1%, twice daily

28 days

×3.0 vs T0

IN VIVO

Firming

1%, twice daily

7 days

×2.2 vs T0

IN VIVO

Plumping

1%, twice daily

7 days

×3.4 vs T0

IN VIVO

Transparency note: The Vitant Collagen Quench Jelly Mask contains Collage™ at 1% — the concentration used in the twice-daily 28-day in vivo study. The instant single-application results (-13.7% wrinkle reduction, +24.9% hydration at 10 minutes) are from the 3% clinical study. The 1% data is the correct reference for the product as formulated, and it shows clinically meaningful outcomes over the 28-day usage period.

The Comparison You’ve Been Waiting For

Collagen Form Mechanism Evidence Quality Vitant / Vitadurance Product
Hydrolysed collagen drinks / powders Amino acid precursor supply (non-specific) Weak — largely industry-funded; inconsistent in independent trials Not used
Native undenatured Type II collagen Oral tolerance — cartilage-specific immune modulation Moderate — mechanism well-documented for arthritis Joint Active (40mg)
Eggshell membrane (INNAĪN® ESM®) Native multi-type collagen matrix: Types I, V, X + Elastin + GAGs Strong — multiple RCTs with validated objective endpoints (VAS, WOMAC) Joint Active (500mg)
Topical Collage™ (ALGAKTIV®) Direct dermal delivery of amino acid substrates + spermidine gene activation (COL1A1, COL3A1) Strong in vitro + in vivo data; bypasses digestion entirely Collagen Quench Jelly Mask

The Inside-Out Approach

For comprehensive collagen support, the most logical strategy addresses both layers simultaneously:

  • Internally (Vitadurance Joint Active): ESM® provides the native structural collagen matrix for tendons, ligaments, fascia, and joints; native undenatured Type II addresses cartilage-specific immune tolerance; Curcumin (95%, 10mg) reduces the systemic inflammation that degrades connective tissue; Boswellia serrata (100mg) targets joint-specific inflammatory pathways; Vitamin K (Menaquinone, 45µg) supports calcium utilisation and bone matrix.
  • Topically (Vitant Collagen Quench Jelly Mask): Collage™ at 1% delivers vegan collagen amino acids and spermidine directly to the dermis for targeted collagen synthesis support, with +24.9% hydration and measurable firming over 28 days of consistent use.

This is not a theoretical framework. It is the approach I use myself and have formulated specifically to address the limitations of the conventional collagen market.

The Bottom Line

If you have been spending significant money on hydrolysed collagen drinks and not noticing a meaningful, objective difference: the independent science suggests your scepticism is well-founded.  If you want collagen support with genuine biological rationale and clinical data measured by the same tools used in pharmaceutical research — you now know which forms to look for, and why.  As always: no hype. Only science.

Vitadurance Regulatory Disclaimer: This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA). This product is not intended to diagnose, treat, cure or prevent any disease.